Výsledky vyhledávání - "Rob, Van Marum"

Akademický článek

Prevalence of potentially inappropriate medications according to STOPP-Frail criteria in nursing home residents, the SHELTER study

Autor: Alireza Malek Makan, Hein van Hout, Graziano Onder, Harriet Finne-Soveri, Daniela Fialova, Rob van Marum

Publikováno v: BMC Geriatrics, Vol 24, Iss 1, Pp 1-9 (2024)

Abstract Objective The aim of this study was to determine the prevalence of potentially inappropriate medications (PIMs) in nursing home residents across eight countries and investigate differences between residents with and without cognitive impairm

Externí odkaz: https://doaj.org/article/1d7cd7b12c49465da6c39b7982d374a9

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Usual care and management of fall risk increasing drugs in older dizzy patients in Dutch general practice

Autor: Hanneke Stam, Thomas Harting, Marjolijn van der Sluijs, Rob van Marum, Henriëtte van der Horst, Johannes C. van der Wouden, Otto R. Maarsingh

Publikováno v: Scandinavian Journal of Primary Health Care, Vol 34, Iss 2, Pp 165-171 (2016)

Objective: For general practitioners (GPs) dizziness is a challenging condition to deal with. Data on the management of dizziness in older patients are mostly lacking. Furthermore, it is unknown whether GPs attempt to decrease Fall Risk Increasing Dr

Externí odkaz: https://doaj.org/article/247d31e9f85446f7a8cc46b98fdfb1c7

Zobrazit plný text záznamu

Plný text ve formátu HTML

Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients

Autor: Jamila Abou, Stijn Crutzen, Vashti Tromp, Mette Heringa, Rob Van Marum, Petra Elders, Katja Taxis, Petra Denig, Jacqueline Hugtenburg

Publikováno v: Drugs & Aging, 39(3), 209-221. ADIS INT LTD
Abou, J, Crutzen, S, Tromp, V, Heringa, M, van Marum, R, Elders, P, Taxis, K, Denig, P & Hugtenburg, J 2022, ' Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients : A Focus Group Study ', Drugs and Aging, vol. 39, no. 3, pp. 209-221 . https://doi.org/10.1007/s40266-021-00918-7
Drugs and Aging, 39(3), 209-221. Adis International Ltd

INTRODUCTION: Benefits and risks of preventive medication change over time for ageing patients and deprescribing of medication may be needed. Deprescribing of cardiovascular and antidiabetic drugs can be challenging and is not widely implemented in d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b95ab91bed04103f25f04f9f222299
https://research.rug.nl/en/publications/38b0770b-6b47-43fd-b05e-7a14b44251af

Zobrazit plný text záznamu

Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease

Publikováno v: Ingala, S, van Maurik, I S, Altomare, D, Wurm, R, Dicks, E, van Schijndel, R A, Zwan, M, Bouwman, F, Schoonenboom, N, Boelaarts, L, Roks, G, van Marum, R, van Harten, B, van Uden, I, Claus, J, Wottschel, V, Vrenken, H, Wattjes, M P, van der Flier, W M & Barkhof, F 2022, ' Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease ', European Radiology, vol. 32, no. 11, pp. 7789-7799 . https://doi.org/10.1007/s00330-021-08503-7, https://doi.org/10.1007/s00330-021-08503-7
European Radiology. Springer Verlag
European Radiology, 32(11), 7789-7799. Springer Verlag

Objectives Neurodegeneration in suspected Alzheimer’s disease can be determined using visual rating or quantitative volumetric assessments. We examined the feasibility of volumetric measurements of gray matter (GMV) and hippocampal volume (HCV) and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09784f91f3a8e59f993384acab5fe04e
https://research.vumc.nl/en/publications/b715f381-d382-4f51-8157-e938f03095f8

Zobrazit plný text záznamu

Effect of conventional haemodialysis on the apixaban plasma concentration

Autor: Tim Poel, Nikki de Rouw, Nathalie Péquériaux, Daan Van de Kerkhof, Annemieke Vermeulen Windsant, Rob van Marum, Angèle Kerckhoffs

Apixaban is a factor Xa inhibitor and is used in patients undergoing haemodialysis treatment. Apixaban can be cleared by haemodialysis, which might lead to decreased apixaban plasma concentrations and insufficient anticoagulation during and after hae

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6fe95fefd205889d4c93692464c8e05a
https://doi.org/10.22541/au.164873558.88065474/v1

Zobrazit plný text záznamu

Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study

Publikováno v: Journal of Critical Care, 57, 134. Elsevier BV
Journal of Critical Care, 57, 134-140. Elsevier
Journal of critical care, 57, 134-140. Elsevier BV
Bakker, T, Klopotowska, J E, de Keizer, N F, van Marum, R, van der Sijs, H, de Lange, D W, de Jonge, E, Abu-Hanna, A & Dongelmans, D A 2020, ' Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions-Results of a multicenter Delphi study ', Journal of Critical Care, vol. 57, pp. 134-140 . https://doi.org/10.1016/j.jcrc.2020.02.012
Journal of Critical Care, 57, 134-140. W B SAUNDERS CO-ELSEVIER INC
Journal of Critical Care, 57, 134-140. Elsevier BV

Purpose: Drug-drug interactions (DDIs) may cause adverse outcomes in patients admitted to the Intensive Care Unit (ICU). Computerized decision support systems (CDSSs) may help prevent DDIs by timely showing relevant warning alerts, but knowledge on w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e20958a54ac117de80ac363386461c3
https://pubmed.ncbi.nlm.nih.gov/32145656

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání